CNMD (Conmed) Cyclically Adjusted FCF per Share: $3.18 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNMD Conmed Corp CNMD
80 GF Score
Price $51.38
GF Value $67.46
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Conmed Cyclically Adjusted FCF per Share?

Conmed CNMD +0.25% 80 Cyclically Adjusted FCF per Share is $3.18 as of Jun. 2026. GuruFocus rates CNMD with a GF Score™ of 80/100 and a GF Value™ of $67.46 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Conmed's adjusted free cash flow per share for the three months ended in Jun. 2026 was $1.134. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $3.18 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Conmed's average Cyclically Adjusted FCF Growth Rate was 17.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.70% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Conmed was 11.70% per year. The lowest was -1.80% per year. And the median was 5.20% per year.

As of today (2026-08-21), Conmed's current stock price is $51.38. Conmed's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $3.18. Conmed's Cyclically Adjusted Price-to-FCF of today is 16.16.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 10.54. And the median was 38.61.


Conmed  (NYSE:CNMD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Conmed's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=51.38/3.18
=16.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 10.54. And the median was 38.61.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Conmed Cyclically Adjusted FCF per Share Related Terms


Conmed Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Conmed's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed Cyclically Adjusted FCF per Share Chart

Conmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.24 2.09 2.21 2.53 2.91

Conmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.70 2.82 2.91 3.09 3.18

CNMD vs ATEC, AORT, IRMD: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Conmed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Conmed's Cyclically Adjusted Price-to-FCF falls into.


CNMD
80GF Score
Conmed Corp CNMD
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conmed Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Conmed's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.134/333.9520*333.9520
=1.134

Current CPI (Jun. 2026) = 333.9520.

Conmed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.787 241.428 1.089
201612 0.335 241.432 0.463
201703 0.456 243.801 0.625
201706 0.465 244.955 0.634
201709 0.345 246.819 0.467
201712 0.608 246.524 0.824
201803 0.743 249.554 0.994
201806 0.593 251.989 0.786
201809 -0.004 252.439 -0.005
201812 0.689 251.233 0.916
201903 -0.274 254.202 -0.360
201906 0.566 256.143 0.738
201909 1.065 256.759 1.385
201912 1.159 256.974 1.506
202003 0.030 258.115 0.039
202006 0.063 257.797 0.082
202009 1.082 260.280 1.388
202012 0.527 260.474 0.676
202103 0.613 264.877 0.773
202106 0.964 271.696 1.185
202109 0.491 274.310 0.598
202112 0.933 278.802 1.118
202203 -0.096 287.504 -0.112
202206 0.438 296.311 0.494
202209 0.617 296.808 0.694
202212 -0.567 296.797 -0.638
202303 -0.260 301.836 -0.288
202306 0.696 305.109 0.762
202309 1.285 307.789 1.394
202312 1.636 306.746 1.781
202403 0.866 312.332 0.926
202406 1.277 314.175 1.357
202409 1.536 315.301 1.627
202412 1.261 315.605 1.334
202503 1.212 319.799 1.266
202506 0.754 322.561 0.781
202509 1.562 324.800 1.606
202512 1.323 324.054 1.363
202603 0.346 330.213 0.350
202606 1.134 333.952 1.134

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $3.18 mean?
Conmed (CNMD) has a Cyclically Adjusted FCF per Share of $3.18 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Conmed and its competitors.
Is Conmed's Cyclically Adjusted FCF per Share too high?
Conmed's current Cyclically Adjusted FCF per Share is $3.18. Overall, Conmed has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Conmed's Cyclically Adjusted FCF per Share compare to ATEC and AORT?
Conmed's Cyclically Adjusted FCF per Share of $3.18 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Conmed and its competitors. Conmed's current Cyclically Adjusted FCF per Share is $3.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Based on GuruFocus' analysis, Conmed (CNMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $67.46, compared to a current price of $51.38 — trading 23.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $3.18. Conmed's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Conmed (CNMD), the current Cyclically Adjusted FCF per Share is $3.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (CNMD) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of $51.38 is trading 23.8% below its estimated GF Value™ of $67.46. GuruFocus considers Conmed to be Modestly Undervalued.

Key valuation signals for CNMD:

  • Cyclically Adjusted FCF per Share: $3.18
  • GF Value™: $67.46 vs. price of $51.38 (23.8% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the CNMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Conmed Business Description

Other Exchanges EC8:Germany
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
80GF Score

Get the complete analysis for CNMD

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$51.38
Price
$67.46
GF Value